Comprehensive Analysis of Thrombotic Microangiopathy Following Renal Transplantation
Conclusion: In this study, PT-TMA was associated with other risk factors besides CNI exposure, with differences by time of onset from transplantation. Prognosis was generally poor but better for early-onset PT-TMA managed with eculizumab. The development of late EPTLD in 3 patients raises concerns.
Saved in:
| Main Authors: | Ittai Fattal, Tali Steinmetz, Natalie Donin, Ana Foigelman Tobar, Benaya Rozen-Zvi, Ruth Rahamimov, Eviatar Nesher, Idit Shirazi, Eytan Mor, Ilan Babai, Zvi Fishelson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/ijne/4396051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01) -
THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01) -
Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes
by: Hannah Beckwith, et al.
Published: (2025-06-01) -
Comments on a problem of thrombotic microangiopathy associated with advanced cancer
by: L. B. Filatov
Published: (2022-11-01) -
Thrombotic Microangiopathy: A Devastating Complication After Lung Transplantation
by: Wouter Rosseels, MD, et al.
Published: (2025-04-01)